Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026
Imported from official source
PRAC starts review of depression and anxiety medicine Deanxit (flupentixol/melitracen)PRAC has started a review of Deanxit, a fixed-dose combination medicine for treating…, Agenda Agenda of the PRAC meeting 26 - 29 October 2026Draft Reference Number: EMA/PRAC/227255/2026…, PRAC statistics: November 2026 Monthly figures for PRAC outcomes based on the draft agenda. , PRAC statistics:…, Ongoing referrals Procedure: Flupentixol/melitracen-containing medicinal products - referralProcedure: Parenteral iron-containing medicinal products - referral, Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association between…
This version
- Version
- 1 of 1
- Recorded
- October 30, 2026 12:00
- Change
- Initial
- Content hash
e1b26a5629dff99710f11a68b4b8e4d1- All versions
- Revision history